QuantLogix's current estimate for Owkin, published 2026-09-12 — below the last disclosed round of $1.3B (2021-Q4).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$1.3B
2021-Q4
weight 0.04
Secondary market print
$1.1B
2026-06-27
weight 0.63
How this price has held up
No round has priced for Owkin since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-12 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Owkin, 2026-09-12 (14bf30945ea97f3b).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Owkin going public?
No. Owkin is private and has not filed to go public. There is no S-1 on file.
What is Owkin's valuation in 2026?
Owkin is valued at $1.3B as of 2021-Q4, set by its Series B ($180M, Nov 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Owkin filed an S-1?
No public S-1 is on file for Owkin.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2016
HQ
Paris, France
Employees
325
Total Raised
$254.1M
Last Round
Series B — $180M (Nov 2021)
IPO Status
private
Fundraising Status
Series B · $180M · 4y 10mo ago
privateTotal raised $254.1M
Secondary Market
Implied price / share
$36.88
Last round price / share
$43.04
vs last round
-14.3%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
heavy product build — 67% of open roles are product-building functions (engineering/research/product) — 2 of 6 open roles are other.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Senior Software Engineer (Platform)Senior AI ScientistSoftware EngineerSoftware Engineering / Machine Learning Engineering InternDirector, Biopharma Data ScienceTeam Lead, Platform Services
Counted from Owkin's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q4. Refreshed quarterly.